Silexion Therapeutics (SLXN) Share-based Compensation (2023 - 2026)
Silexion Therapeutics (SLXN) recorded Share-based Compensation of $197,000 in Q2 2026, up 432.4% from $37,000 a year earlier but down 42.9% from the prior quarter.
Powered by 
Analysis
Silexion Therapeutics (SLXN) Share-based Compensation (2023 - 2026) Analysis & Trends
On a TTM basis, Silexion Therapeutics' Share-based Compensation came in at $618,000 as of Jun 30, 2026, down 89.4% year-over-year; for FY2025, it was $134,000, down 97.7% from FY2024.
- Across earlier years, Share-based Compensation came in at $5.86 million in FY2024 and $130,000 in FY2023.
- Quarterly Share-based Compensation has ranged from $21,000 in Q1 2025 to $5.8 million in Q3 2024 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in two of the last four quarters, with growth averaging 78.6%.
- Per Business Quant, the preceding three quarters came in at $345,000 (Q1 2026), $38,000 (Q4 2025) and $38,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.84 Bn | 1,106.42 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 618.03 Bn | 536.55 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 507.69 Bn | 480.80 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.91 Bn | 321.28 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.54 Bn | 262.53 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 263.16 Bn | 236.84 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.31 Bn | 191.71 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 192.91 Bn | 167.11 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.40 Bn | 118.04 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Silexion Therapeutics | 115,475.30 | -19.76 Mn | - | 197,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 197,000.00 |
| Mar 31, 2026 | 345,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Sep 30, 2025 | 38,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Sep 30, 2024 | 5.80 Mn |
| Jun 30, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 32,000.00 |
API Access
Silexion Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SLXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SLXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SLXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();